Melinda Wenner Moyer (@Lindy2350) is a science writer based in New York’s Hudson Valley. She is a visiting scholar at NYU’s Arthur L. Carter Journalism Institute and an Alicia Patterson fellow. Moyer writes a column for Slate and is a contributing editor at Scientific American. Her work has also appeared in the New York Times, Mother Jones, and a number of women’s magazines.

Melinda Wenner Moyer
From this contributor
When autistic people commit sexual crimes
Many first-time sex offenders on the spectrum may not understand the laws they break. How should their crimes be treated?

When autistic people commit sexual crimes
How pregnancy may shape a child’s autism
Autism is predominantly genetic in origin, but a growing list of prenatal exposures for mother and baby may sway the odds.

How pregnancy may shape a child’s autism
Explore more from The Transmitter
On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.

On the importance of reading (just not too much)
The real fun of being a neuroscientist, and maybe the key to asking and answering new questions, is to think big and take intellectual risks.
How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.

How developing neurons simplify their search for a synaptic mate
Streamlining the problem from 3D to 1D eases the expedition—a strategy the study investigators deployed to rewire an olfactory circuit in flies.
NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.

NIH autism database announcement raises concerns among researchers
The U.S. National Institutes of Health announced a plan to pour $50 million into data science projects intended to investigate the condition’s causes, but the initiative’s short timeline and other atypicalities have prompted questions.